Logo image of OGI

ORGANIGRAM GLOBAL INC (OGI) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:OGI - CA68617J1003 - Common Stock

1.76 USD
+0.02 (+1.15%)
Last: 12/24/2025, 7:53:35 PM
1.77 USD
+0.01 (+0.57%)
After Hours: 12/24/2025, 7:53:35 PM

OGI Key Statistics, Chart & Performance

Key Statistics
Market Cap236.42M
Revenue(TTM)259.18M
Net Income(TTM)-24.76M
Shares134.33M
Float90.63M
52 Week High2.24
52 Week Low0.85
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.18
PEN/A
Fwd PE210.72
Earnings (Next)02-09 2026-02-09
IPO2011-11-24
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


OGI short term performance overview.The bars show the price performance of OGI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20 30

OGI long term performance overview.The bars show the price performance of OGI in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 -40

The current stock price of OGI is 1.76 USD. In the past month the price increased by 9.32%. In the past year, price increased by 8.64%.

ORGANIGRAM GLOBAL INC / OGI Daily stock chart

OGI Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 48.98 1.02T
JNJ JOHNSON & JOHNSON 20.02 500.60B
MRK MERCK & CO. INC. 12.08 264.21B
PFE PFIZER INC 7.82 142.31B
BMY BRISTOL-MYERS SQUIBB CO 8.34 111.38B
ZTS ZOETIS INC 19.79 55.30B
RPRX ROYALTY PHARMA PLC- CL A 9.55 22.66B
VTRS VIATRIS INC 5.25 14.10B
ELAN ELANCO ANIMAL HEALTH INC 23.31 11.12B
CORT CORCEPT THERAPEUTICS INC 94.99 8.79B
AXSM AXSOME THERAPEUTICS INC N/A 7.74B
BLTE BELITE BIO INC - ADR N/A 5.41B

About OGI

Company Profile

OGI logo image Organigram Global, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. The company is headquartered in Moncton, New Brunswick and currently employs 1,178 full-time employees. The company went IPO on 2011-11-24. The company has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. The company operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. The company operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.

Company Info

ORGANIGRAM GLOBAL INC

35A English Dr

Moncton NEW BRUNSWICK E1E 3X3 CA

CEO: Greg Engel

Employees: 1093

OGI Company Website

OGI Investor Relations

Phone: 15063841571

ORGANIGRAM GLOBAL INC / OGI FAQ

Can you describe the business of ORGANIGRAM GLOBAL INC?

Organigram Global, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. The company is headquartered in Moncton, New Brunswick and currently employs 1,178 full-time employees. The company went IPO on 2011-11-24. The company has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. The company operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. The company operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.


What is the stock price of ORGANIGRAM GLOBAL INC today?

The current stock price of OGI is 1.76 USD. The price increased by 1.15% in the last trading session.


Does OGI stock pay dividends?

OGI does not pay a dividend.


How is the ChartMill rating for ORGANIGRAM GLOBAL INC?

OGI has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Can you provide the PE ratio for OGI stock?

ORGANIGRAM GLOBAL INC (OGI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.18).


What is the market capitalization of OGI stock?

ORGANIGRAM GLOBAL INC (OGI) has a market capitalization of 236.42M USD. This makes OGI a Micro Cap stock.


Who owns ORGANIGRAM GLOBAL INC?

You can find the ownership structure of ORGANIGRAM GLOBAL INC (OGI) on the Ownership tab.


OGI Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to OGI. When comparing the yearly performance of all stocks, OGI turns out to be only a medium performer in the overall market: it outperformed 60.53% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

OGI Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to OGI. OGI may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

OGI Financial Highlights

Over the last trailing twelve months OGI reported a non-GAAP Earnings per Share(EPS) of -0.18. The EPS increased by 60.25% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -4.4%
ROE -7.09%
Debt/Equity 0.22
Chartmill High Growth Momentum
EPS Q2Q%-258.7%
Sales Q2Q%79.12%
EPS 1Y (TTM)60.25%
Revenue 1Y (TTM)62.15%

OGI Forecast & Estimates

For the next year, analysts expect an EPS growth of 104.73% and a revenue growth 22.53% for OGI


Analysts
Analysts77.5
Price TargetN/A
EPS Next Y104.73%
Revenue Next Year22.53%

OGI Ownership

Ownership
Inst Owners7.69%
Ins Owners2.61%
Short Float %5.39%
Short Ratio8.05